Fate’s approach to off-the-shelf cancer immunotherapy
Seminar of the KG Jebsen Center for Cancer Immunotherapy, co-hosted by Oslo Cancer Cluster
Speaker: Bob Valamehr, Vice President, Cancer Immunotherapy at Fate Therapeutics Inc
Moderator: Kalle Malmberg, KG Jebsen Center for Cancer Immunotherapy
Program will be available soon. Here is the invitation: